Zelira Therapeutics Ltd ZLDAF
$0.26
Last Updated: Aug 11, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
ZLDAF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Zelira Therapeutics Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Zelira Therapeutics Ltd. Stock Analysis ZLDAF
United States Health Care Nano Cap Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. The firm is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. The company owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. The company is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. The company has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The firm in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.
Zelira Therapeutics Ltd (ZLDAF) Chart
Financial Metrics & Statements of Zelira Therapeutics Ltd (ZLDAF)
FAQ's for Zelira Therapeutics Ltd (ZLDAF)
- As of August 2026, Zelira Therapeutics Ltd ZLDAF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Zelira Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Zelira Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Zelira Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Zelira Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Zelira Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Zelira Therapeutics Ltd (ZLDAF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
